棉花品种抗黄萎病性与体内生化成分相关分析

对棉花不同抗感黄萎病性品种生化成分分析结果表明:棉花品种在无菌土中体内可溶性还原糖含量相应地高于接菌土中的含量。蕾期抗耐品种平均含量为2.276％,高于感性品种的1.417％,而铃期趋势相反。叶片单宁含量高于根部。在无菌土中,抗耐品种叶片单宁含量平均为3.58％,高于感病品种的3.28％;而在接菌条件下趋势相反。根部棉酚含量显著高于叶部,但两者极显著相关。在无菌土和接菌土中,抗性品种棉酚含量均高于耐性品种,而耐性品种又高于感性品种。棉株体内棉酚含量与棉花品种抗黄萎病性显著正相关。同工酶谱测定显示,过氧化物酶在抗感品种的无病症叶片中,酶带特征基本一致,叶片显症后表现主酶带区加宽,主酶带数增多,变化趋势与症状严重度正相关。在显症条件下,抗性品种酯酶同工酶活性略强于感性品种;与无症叶相比,显症叶的SOD酶带数由原来的4—6条减少至3—4条,抗性品种的酶带数少于感性品种1—2条。     

应用尼氏钝绥螨防治大棚草莓上硃砂叶螨的研究初报

尼氏钝绥螨(Amblyseius nicholsi Ehare＆Lee)能捕食硃砂叶螨(Tetranychuscinnabarinus Boisduval)各螨态,对卵的捕食量显著地高于其他螨态,其雌成螨对硃砂叶螨若螨的功能反应为HollingⅡ反应,在草莓大棚内释放尼氏钝绥螨能较好地防治硃砂螨叶     

银纹夜蛾人工饲养技术研究

本文在研究了各种环境因子对银纹夜蛾实验种群影响的基础上，进一步研究了食量，低温保种及饲养管理技术，设计了一种便于收集卵的新型产卵笼，并总结了人工饲养银纹夜蛾的技术要点。     

苹果枝梢化学成分与对苹果绵蚜抗性的比较

果树对苹果绵蚜的抗性与多种因素有关。其中营养成分α-氨基氮的含量,以及毒性成分多酚(φ)的含量尤为重要。     

小地老虎抗寒能力的研究

小地老虎各虫态的过冷却点,卵期为-9.5℃,一至六龄幼虫分别为-8.8、-4.1、-3.6、-3.0、-2.3与-1.2℃,蛹期为-6.6℃,成虫期为-4.3℃。越冬幼虫在-5—0℃下1天内即死亡,2—4℃间能存活2个月,低温锻炼不能提高幼虫的抗寒力。六龄幼虫在4℃时停食,消化道内酯酶活性下降。成虫在越冬期间,若无补充营养,只能存活2个月。     

制备植物病毒、细菌抗血清的连续采血法研究和应用

用植物病毒、细菌抗源(加福氏完全佐剂)免疫家兔,从末次免疫后7天开始,1—5个月内进行耳静脉连续采血,1周2次,能获得比心脏采血多15倍的抗血清。耳静脉抗血清用于酶联免疫吸附试验、免疫电镜、反向间接血凝、乳胶凝集试验、免疫双扩散、对流免疫电泳技术检测抗原,均得到很好的结果。     

苹果树腐烂病(Valsa malimiyabe et Yamada)侵染时期研究

 本文报导了苹果树腐烂病侵染时期的研究结果.明确了我国辽宁西部的兴城,从3月至11月均能发生侵染,从3月下旬至5月中旬侵染最为集中.就树皮腐生真菌对腐烂病菌侵染的影响做了初步探索.     

Cryopreservation of gander semen

1. The effect of dimethylacetamide (DMA) and dimethyl sulphoxide (DMSO) on the cryopreservation of gander semen were investigated. An improved survival rate of spermatozoa after freeze-thawing was obtained when semen was frozen by a fast-freezing procedure on dry ice with 9% DMA as the cryoprotectant. 2. Gander semen, which was frozen during mid season, was tested for fertilising ability in different times of the season. The percentage of fertility during d 3 to d 9 after 2 consecutive inseminations was 68% to 95%, depending on the date of artificial insemination.     

Effects of chromium nicotinate on performance, carcase characteristics and blood chemistry of growing turkeys

1. The objective of this trial was to study the effects of chromium nicotinate (Cr) supplementation on the performance, carcase characteristics and blood constituents of 9 to 22 week-old male turkeys. 2. Fifty-four 8-week-old male turkeys weighing 2.9 +/- 0.28 kg were allocated at random into 9 groups with 3 dietary treatments and 3 replicates. The dietary treatment was different dietary concentrations of chromium in the basal diet, to provide 0 (control), 1 or 3 mg/kg. The feeding trial lasted for 14 weeks. 3. Results showed that 1 mg/kg chromium supplementation significantly improved weight gain and food intake at 9 to 18 weeks of age but did not significantly influence performance at 19 to 22 week of age. The breast and thigh muscle were significantly increased in birds receiving 1 mg/kg chromium supplementation but were decreased by 3 mg/kg of supplementation. 4. Dietary chromium supplementation did not significantly influence other serum constituents, including insulin, HDL, VLDL+LDL, HDL-C, VLDL-C+LDL-C, total protein, albumin, and gamma-globulin at 18 and 22 weeks of age. 5. The serum triacylglycerol (TG) and uric acid contents were significantly increased, while glycerol and alpha-globulin were significantly reduced by 3 mg/kg chromium supplementation. However, 1 mg/kg chromium supplementation significantly reduced serum cholesterol and glycerol at 18-weeks old. At 22 weeks of age, 1 mg/kg chromium supplementation significantly increased serum glucose and decreased the uric acid concentration whereas 3 mg/kg chromium supplementation significantly increased the creatinine concentration and decreased beta-globulin concentration.     

Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia)

A canine model of glycogen storage disease Ia (GSD Ia), similar clinically, biochemically, and pathologically to the human disease, was established by crossbreeding Maltese and Beagle dogs carrying a mutated, defective glucose-6-phosphatase (G-6-Pase) gene. Ten puppies were born in three litters from these crossbreedings. Six were homozygous for the previously described M121I GSD Ia mutation. Of these six affecteds, two were stillborn, and one died at 2, 32, and 60 days of life, respectively (puppies A, B, C, D, E), while one is alive at age 15 months (puppy F). Affected puppies exhibited tremors, weakness, and neurologic signs when hypoglycemic. They had postnatal growth retardation and progressive hepatomegaly. Biochemical abnormalities included fasting hypoglycemia, hyperlactacidemia, hypercholesterolemia, hypertriglyceridemia, and hyperuricemia. Microscopic examination of tissues from affected puppies showed diffuse, marked hepatocellular vacuolation, with distended clear hepatocytes and central to marginally located rounded nuclei. In the kidneys of puppies D and E, there was segmental glomerular sclerosis and vacuolation of proximal convoluted tubular epithelium. Biochemical analysis revealed increased liver glycogen content and isolated markedly reduced G-6-Pase enzyme activity in liver and kidney. The canine G-6-Pase gene was characterized by screening a canine genomic library. It spans approximately 11.8 kb and consists of five exons with >90% amino acid sequence homology to the derived human sequence. The first 1.5 kb of the 5' region was sequenced and contains several putative response element motifs homologous to the human 5' region. Establishment of this canine colony of GSD Ia that closely resembles human disease and isolation of the canine genomic gene provides an excellent model for studying pathophysiology and long-term complications and an opportunity to develop novel therapeutic approaches such as drug and gene therapy.